Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway. - Wikidata - awgldk - TriplyDB

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.

http://www.wikidata.org/entity/Q34979275

about

Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury.Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells.Zoledronate attenuates angiogenic effects of angiotensin II-stimulated endothelial progenitor cells via RhoA and MAPK signaling.Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration.The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes.New approaches to the design and discovery of therapies to prevent erectile dysfunction.Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction.Arginase in retinopathy.Effect of arginase inhibition on pulmonary L-arginine metabolism in murine Pseudomonas pneumonia Arginase inhibition enhances angiogenesis in endothelial cells exposed to hypoxia.Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions.Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathway Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway.Diabetes-induced vascular dysfunction involves arginase I Treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restores endothelial function in rat adjuvant-induced arthritis.Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.Role of arginase in vessel wall remodeling.Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation.Arginase 1 mediates increased blood pressure and contributes to vascular endothelial dysfunction in deoxycorticosterone acetate-salt hypertension Arginase 1: an unexpected mediator of pulmonary capillary barrier dysfunction in models of acute lung injury.Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation Dihydrotestosterone modulates endothelial progenitor cell function via RhoA/ROCK pathway.Induction of microRNA-138 by pro-inflammatory cytokines causes endothelial cell dysfunction.Targeting RhoA/ROCK pathway in pulmonary arterial hypertension.Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications.Pharmacological treatment and therapeutic perspectives of metabolic syndrome.Arginase: an old enzyme with new tricks.Clinical Significance of Endothelial Dysfunction in Essential Hypertension.The role of perivascular adipose tissue in obesity-induced vascular dysfunction Angiotensin II-Induced Early and Late Inflammatory Responses Through NOXs and MAPK Pathways.Hepatic metal ion transporter ZIP8 regulates manganese homeostasis and manganese-dependent enzyme activity.The High Blood Pressure-Malaria Protection Hypothesis.Local renin-angiotensin system mediates endothelial dilator dysfunction in aging arteries.Angiotensin II-Induced Apoptosis of Human Umbilical Vein Endothelial Cells was Inhibited by Blueberry Anthocyanin Through Bax- and Caspase 3-Dependent Pathways.

P2860

Q28073279-1970BA9D-C15A-47C3-BB74-49F7386D57AC Q28076034-FA7015D5-9885-4E1E-BC43-89AEC4F5C038 Q28390079-69B73F57-67F1-4EE2-BAB9-F0124FBB557F Q30540011-21A96FF7-8452-4FCF-9CC8-D6C2A64D0570 Q33829848-5DF64D33-A2CF-4B1F-A1E2-AACC142070FF Q34447189-0B62D10F-FDF0-4F1F-ABD3-2E7D3ABD368F Q34465434-F3BA65D6-8F60-4BB0-96D9-E430DDDD890A Q34509144-2FA85BCB-2762-4CF2-A1ED-2CCA24B39D09 Q34664336-E201D505-C0CA-4EE4-8C41-00296327FF4C Q34797559-BD9612EC-7B9A-4CAE-880E-D64F25A568BA Q34800913-36B5D0D1-8384-40D9-A462-72D1013AF589 Q35111227-E80E1F15-1060-41B5-B85C-BFB834C5A716 Q35181215-F1009329-203F-4C76-AE3C-9F58C61CDD4E Q35217395-39E30558-8753-40C0-AA05-6BB73946593D Q35223489-25A74720-85A3-4165-AA86-74957267BB4C Q35545549-6DC9670A-BC99-4DA5-A2FB-6AE288F3A8B5 Q35708220-6EA3A8FE-5B4C-4CCA-9230-7363D079A8F8 Q35906453-82293DF7-C3CB-4D2D-BDB8-321E2179AAFC Q36246065-3E8D2CB0-1294-4C65-9A94-D82A738E47CC Q36787307-98799441-1E32-4A5D-86AC-865A29353024 Q36837617-95312D75-6DC8-4D27-AA8D-631394392B03 Q36920831-E2F2AF15-343E-4E5F-ABCA-22565066C986 Q37050646-4BCA0109-2251-4130-84F0-511D0B890197 Q37076835-C23B01AA-C22C-4D22-9994-F95C1BAC5DDC Q37102697-1E6C1BB0-9CFC-40EE-B83F-539D5C3729F8 Q37231836-64DA9562-0417-49C3-A420-F23DB2945E4A Q37252197-D7C385EB-2437-467F-B4A3-25A7866C4624 Q37393444-6B741E0F-EEAC-4907-97E4-83894EBBA083 Q37683440-96952E29-8C04-49AB-8B5E-D72E82BA227A Q37997101-F6F98391-F0EA-47BE-838C-23DCBC1E6E37 Q38170474-1C96E4D5-2A7F-4A63-A597-99C096BDEEC3 Q38262435-4CC6EF83-0C64-4F71-A37E-1F42E4F76DB8 Q38452432-44D9ACAA-D9C9-4197-88DF-205FB444C5F5 Q38586940-F4D1B196-C8DA-438C-8105-DA9A2E30C644 Q38985853-6E440F69-16F7-48EA-A4A1-3BD9BDDFA668 Q39222114-651C826D-C5C7-4EED-A811-E45141EA92E1 Q40211154-EC3A889D-6B81-4E2B-B903-A6D3892ACD9A Q40509426-E486DFFB-5040-4405-A020-B6CA9AC8FEDA Q40976363-C8C9EFD7-BD1B-484C-9A7D-55DBE3425F56 Q41130376-8CA9DE24-C7B0-4C23-AAF7-6E60BA384A58

P2860

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.

http://www.wikidata.org/entity/Q34979275

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Angiotensin II-induced vascula ...... otein kinase/arginase pathway.

@ast

Angiotensin II-induced vascula ...... otein kinase/arginase pathway.

@en

Angiotensin II-induced vascula ...... otein kinase/arginase pathway.

@nl

type

label

Angiotensin II-induced vascula ...... otein kinase/arginase pathway.

@ast

Angiotensin II-induced vascula ...... otein kinase/arginase pathway.

@en

Angiotensin II-induced vascula ...... otein kinase/arginase pathway.

@nl

prefLabel

Angiotensin II-induced vascula ...... otein kinase/arginase pathway.

@ast

Angiotensin II-induced vascula ...... otein kinase/arginase pathway.

@en

Angiotensin II-induced vascula ...... otein kinase/arginase pathway.

@nl

P1433

Q34979275-B6D1370A-E6DE-4FE0-9826-35614A8D2D68

P1476

Q34979275-13685A26-3A50-4651-894F-DEC045BA7590

P2093

Q34979275-2FA58916-84E9-48E2-A612-73C03C7D34E2

Q34979275-3BE7445C-E849-40E8-8FAE-75DF51F4C181

Q34979275-60E21355-7658-4769-A6AF-3065F0CED96B

Q34979275-7782C12E-BE07-4B2E-BBA6-D73E5CA5618A

Q34979275-9234FCEF-AF92-4F2C-82BD-6B1C185E2F52

Q34979275-D3E870A7-EEBB-4EA8-9AAF-49C2E6F69A7D

Q34979275-DED82522-1404-4903-884B-2BACD0645F6D

Q34979275-E26DC9E1-A9EC-4988-9C8A-6C2E766BCCE5

P2860

Q34979275-058B2569-2470-40E2-B387-415CF6958B50

Q34979275-061499C4-1DD7-469F-B635-6E9AA970E746

Q34979275-0654ABC1-45E7-497B-A39E-96FA2D9288A9

Q34979275-09492BEC-9D0C-4310-9441-5B5A7A5510AE

Q34979275-13D8F957-F2C1-495D-A211-3FC4D923D3CE

Q34979275-2050AE2B-B2C6-4869-B3C1-F2AE727C74F6

Q34979275-356D54DC-D115-4281-88A5-8A8DC99BF471

Q34979275-35F6A1E9-7C70-4CB1-81A7-4B3B60308477

Q34979275-38E965FA-4915-4DDF-802F-D925F8BB0918

Q34979275-3DCBA3F0-0F5D-4834-A82E-42A3D32EE16C

P304

Q34979275-C1ABC342-6DB5-494A-A828-2CF0635ABE7F

P31

Q34979275-68F72BA6-26E4-40C2-A58A-2D9E196D3256

P356

Q34979275-2BAFD880-4F06-4B2F-B5F6-B23E82EB34A7

P433

Q34979275-81210702-132C-4048-9E6C-F19D4C53B386

P478

Q34979275-3EDCCBD8-EBED-4103-95E7-BAEB7BE04DB9

P577

Q34979275-4C554C9F-FC1B-45B3-A7F3-9C904E453559

P698

Q34979275-0A011B21-241E-40F3-AF82-73103761D206

P921

Q34979275-17A6AEEC-E1DE-4DC0-AA4A-8944F306F961

P932

Q34979275-65671923-1635-4BF7-B718-05CB98420F4C

P356

AJPCELL.00328.2010

P1433

American Journal of Physiology - Cell Physiology

P1476

Angiotensin II-induced vascula ...... otein kinase/arginase pathway.

@en

P2093

Alexander D Verin

http://www.w3.org/2001/XMLSchema#string

Alia Shatanawi

http://www.w3.org/2001/XMLSchema#string

Jennifer A Iddings

http://www.w3.org/2001/XMLSchema#string

Maritza J Romero

http://www.w3.org/2001/XMLSchema#string

Nagavedi S Umapathy

http://www.w3.org/2001/XMLSchema#string

R William Caldwell

http://www.w3.org/2001/XMLSchema#string

Ruth B Caldwell

http://www.w3.org/2001/XMLSchema#string

Surabhi Chandra

http://www.w3.org/2001/XMLSchema#string

P2860

Mouse model for human arginase deficiency

Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin

Regulation of enzymes of the urea cycle and arginine metabolism

Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages.

Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy.

Thrombin induces endothelial arginase through AP-1 activation.

Inhibition of p38 MAP kinase as a therapeutic strategy.

Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats.

p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice

Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation.

P304

C1181-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPCELL.00328.2010

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

300

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21289285

http://www.w3.org/2001/XMLSchema#string

P921

P932

3093945

http://www.w3.org/2001/XMLSchema#string